Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04191941Early Phase 1Unknown
Treatment of Hematological Malignancy With Novel CAR-T Cells.
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaMultiple Myeloma
PrincipalinvestigatorStart date: 2019-09-01
NCT03497533Phase 1/2Unknown
Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19
Non-hodgkin Lymphoma,B Cell
PrincipalinvestigatorStart date: 2018-08-03

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04191941Early Phase 1PrincipalInvestigator

Treatment of Hematological Malignancy With Novel CAR-T Cells.

B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaMultiple Myeloma
Unknown
NCT03497533Phase 1/2PrincipalInvestigator

Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19

Non-hodgkin Lymphoma,B Cell
Unknown

All 2 trials loaded